ArticleOncology letters2024

Prognosis value of circulating tumor cell PD‑L1 and baseline characteristics in patients with NSCLC treated with immune checkpoint inhibitors plus platinum‑containing drugs.

Xiaona Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.